An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.
Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang D, Chu HW, Lobera M, Yang J, Wilkes DS, Du J, Gartlan K, Hill GR, MacDonald KP, Espada EL, Blanco P, Serody JS, Koreth J, Cutler CS, Antin JH, Soiffer RJ, Ritz J, Paczesny S, Blazar BR.
Forcade E, et al. Among authors: griesenauer b.
JCI Insight. 2017 Jun 15;2(12):e92111. doi: 10.1172/jci.insight.92111. eCollection 2017 Jun 15.
JCI Insight. 2017.
PMID: 28614794
Free PMC article.